Jushi Holdings finalizes Nevada redomicile, unveils new capital structure and governance framework
Summary
Jushi Holdings completed its redomicile to Nevada, adopting new articles that authorize 3 billion shares and bylaws that entrench management. The move finalizes a process approved in June but introduces significant dilution potential and governance changes.
Key Events · Corporate Governance and Compliance · JUSHF
-
Redomicile to Nevada Completed
On July 30, 2026, following shareholder approval on June 24, 2026, Jushi Holdings Inc. completed its continuance from British Columbia to Nevada. The company now operates as a Nevada corporation.
-
Massive Share Authorization Increase
The new Nevada Articles of Incorporation authorize 3,000,000,000 shares — 2,000,000,000 common and 1,000,000,000 preferred — a blank check for future dilution. Previously, the company had unlimited subordinate voting shares but no preferred stock authorization.
-
Entrenching Governance Provisions
New bylaws include a classified board with staggered three-year terms, a supermajority (two-thirds) stockholder vote to remove directors, an exclusive Nevada forum for disputes, and no stockholder right to call special meetings or act by written consent.
-
Equity Plan Amended
The 2019 Equity Incentive Plan was amended to reflect the Nevada incorporation, with conforming changes to award agreements. The plan remains an 'evergreen' with a share reserve of 15% of outstanding common stock plus an additional 2% for inducement grants.
Analysis · JUSHF · Life Sciences
Jushi Holdings has completed its move from British Columbia to Nevada, a step shareholders greenlit in June. The new Nevada articles authorize a staggering 3 billion shares — 2 billion common and 1 billion preferred — effectively a blank check for future dilution. Meanwhile, the new bylaws introduce a classified board, supermajority removal requirements, and an exclusive Nevada forum, all of which entrench management and raise the bar for hostile takeovers. For a company already under a going-concern warning and trading below $0.40, this governance overhaul and expanded share authorization carry material weight.
At the time of this filing, JUSHF was trading at $0.38 on OTC in the Life Sciences sector, with a market capitalization of approximately $82.9M. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.